Abstract
We recently isolated a cDNA for hpttg, the human homolog of rat pituitary tumor transforming gene. Now we have analysed the expression of hpttg as a function of cell proliferation. hPTTG protein level is up-regulated in rapidly proliferating cells, is down-regulated in response to serum starvation or cell confluence, and is regulated in a cell cycle-dependent manner, peaking in mitosis. In addition, we show that hPTTG is phosphorylated during mitosis. Immunodepletion and in vitro phosphorylation experiments, together with the use of a specific inhibitor, indicate that Cdc2 is the kinase that phosphorylates hPTTG. These results suggest that hpttg is induced by, and may have a role in, regulatory pathways involved in the control of cell proliferation.
Similar content being viewed by others
References
Bailly E, McCaffrey M, Touchot N, Zahraoui A, Goud B and Bornens M. . 1991 Nature 350: 715–718.
Belenguer P, Caizergues-Ferrer M, Labbe JC, Doree M and Amalric F. . 1990 Mol. Cell Biol. 10: 3607–3618.
Bradbury EM. . 1992 Bioessays 14: 9–16.
Brinkmann U, Brinkmann E, Gallo M and Pastan I. . 1995 Proc. Natl. Acad. Sci. USA 92: 10427–10431.
Buday L, Warne PH and Downward J. . 1995 Oncogene 11: 1327–1331.
Buendia B, Clarke PR, Felix MA, Karsenti E, Leiss D and Verde F. . 1991 Cold Spring Harb. Symp. Quant. Biol. 56: 523–532.
Chou YH, Bischoff JR, Beach D and Goldman RD. . 1990 Cell 62: 1063–1071.
Colgan DF, Murthy KG, Zhao W, Prives C and Manley JL. . 1998 EMBO J. 17: 1053–1062.
Corbalan-Garcia S, Yang SS, Degenhardt KR and Bar-Sagi D. . 1996 Mol. Cell Biol. 16: 5674–5682.
Domínguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M and Pintor-Toro JA. . 1998 Oncogene 17: 2187–2193.
Gottesfeld JM and Forbes DJ. . 1997 Trends Biochem. Sci. 22: 197–202.
Heichman KA and Roberts JM. . 1994 Cell 79: 557–562.
Hershkovitz M and Riggs AD. . 1995 Proc. Natl. Acad. Sci. USA 92: 2379–2383.
Hirama T and Koeffler HP. . 1995 Blood 86: 841–854.
Hsu SC, Qi M and DeFranco DB. . 1992 EMBO J. 11: 3457–3468.
Jackman MR and Pines JN. . 1997 Cancer Surv. 29: 47–73.
Jin DY, Spencer F and Jeang KT. . 1998 Cell 93: 81–91.
King RW, Jackson PK and Kirschner MW. . 1994 Cell 79: 563–571.
Laemmli UK. . 1970 Nature 227: 680–685.
Luscher B and Eisenman RN. . 1992 J. Cell Biol. 118: 775–784.
Martínez-Balbás MA, Dey A, Rabindran SK, Ozato K and Wu C. . 1995 Cell 83: 29–38.
Moreno S and Nurse P. . 1990 Cell 61: 549–551.
Morgan DO. . 1995 Nature 374: 131–134.
Morgan DO. . 1997 Annu. Rev. Cell Dev. Biol. 13: 261–291.
Nigg EA. . 1991 Semin. Cell. Biol. 2: 261–270.
Nigg EA. . 1995 Bioessays 17: 471–480.
Nurse P. . 1994 Cell 79: 547–550.
Pei L. . 1998 J. Biol. Chem. 273: 5219–5225.
Pei L. . 1999 J. Biol. Chem. 274: 3151–3158.
Pei L and Melmed S. . 1997 Mol. Endocrinol. 11: 433–441.
Peter M, Nakagawa J, Doree M, Labbe JC and Nigg EA. . 1990a Cell 60: 791–801.
Peter M, Nakagawa J, Doree M, Labbe JC and Nigg EA. . 1990b Cell 61: 591–602.
Pines J. . 1995 Adv. Cancer Res. 66: 181–212.
Reed SI. . 1997 Cancer Surv. 29: 7–23.
Sáez C, Japón MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M and Pintor-Toro JA. . 1999 Oncogene 18: 5473–5476.
Satterwhite LL, Lohka MJ, Wilson KL, Scherson TY, Cisek LJ, Corden JL and Pollard TD. . 1992 J. Cell Biol. 118: 595–605.
Sherr CJ. . 1994 Cell 79: 551–555.
Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.
Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H and Cantley LC. . 1994 Curr. Biol. 4: 973–982.
Tuomikoski T, Felix MA, Doree M and Gruenberg J. . 1989 Nature 342: 942–945.
Verde F, Labbe JC, Doree M and Karsenti E. . 1990 Nature 343: 233–238.
Yamashiro S and Matsumura F. . 1991 Bioessays 13: 563–568.
Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD and Melmed S. . 1999a J. Clin. Endocrinol. Metab. 84: 761–767.
Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD and Melmed S. . 1999b Mol. Endocrinol. 13: 156–166.
Zou H, McGarry TJ, Bernal T and Kirschner MW. . 1999 Science 285: 418–422.
Acknowledgements
We thank Dr RM Rios for useful discussions and suggestions and Drs S Gisselbrecht and S Fischer for critical reading of the manuscript. This work was supported by grants from Ministerio de Educación y Ciencia of Spain (SAF96-0275 and SAF99-0125), from DGUI of the Junta de Andalucía, and from Rhône-Poulenc Rorer (Paris).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramos-Morales, F., Domínguez, Á., Romero, F. et al. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19, 403–409 (2000). https://doi.org/10.1038/sj.onc.1203320
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203320
- Springer Nature Limited
Keywords
This article is cited by
-
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
Journal of Hematology & Oncology (2015)
-
Pituitary Tumor Transforming Gene 1 Induces Tumor Necrosis Factor-α Production from Keratinocytes: Implication for Involvement in the Pathophysiology of Psoriasis
Journal of Investigative Dermatology (2013)
-
Pituitary Tumor-Transforming Gene 1 Enhances Proliferation and Suppresses Early Differentiation of Keratinocytes
Journal of Investigative Dermatology (2012)
-
Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells
Clinical & Experimental Metastasis (2012)
-
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction
Breast Cancer Research and Treatment (2012)